NIVB scientists move closer to developing a drug not only against monkeypox

NIVB scientists at Institute of Organic Chemistry and Biochemstry in Prague deciphered the structure of a methyltransferase protein from the monkeypox virus. Due to the protein escapes human immunity and transmits the disease. Based on this discovery, they then prepared substances that can block the function of methyltransferase. The results of this research may constitute the first step towards creating a completely new group of antivirals. This applies not only to monkeypox, but also to diseases caused by other viruses, including COVID-19 induced by the SARS-CoV-2 coronavirus.

A number of media outlets reported on the scientists’ success:




Pozitivní zprávy

Zdravé zprávy


Original article:

Silhan, J.; Klima, M.; Otava, T.; Skvara, P.; Chalupska, D.; Chalupsky, K.; Kozic, J.; Nencka, R.; Boura, E. Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nat Commun 2023, 14, 2259.

Introduction of methods available in our service laboratory with an emphasis on advanced […]

kveten prezentace

We would like to invite you to the regular IMIC seminar, the talk will be given […]

Virologist Daniel Růžek from the Institute of Parasitology of the Czech Academy of Sciences […]

A panel of experts, including scientists from the NIVB project involved in anti-pandemic strategies […]

More information to find: on this link and this link

An expert describes the Marburg virus. More info to be found: on this link

On October 16TH was Iva Pichová awarded by Josefa Hlávky medal. See […]

December 26, 2022

NIVB Meeting 2022

The first annual NIVB meeting took place from 30 November to 2 December […]

© 2023 NIVB